Suppr超能文献

人 PARP15 催化结构域与小分子抑制剂复合物的晶体结构。

Crystal structures of the catalytic domain of human PARP15 in complex with small molecule inhibitors.

机构信息

College of Pharmaceutical Sciences, Gannan Medical University, Ganzhou, 341000, China.

Shenzhen Crystalo Biopharmaceutical Co., Ltd, Shenzhen, 518118, China.

出版信息

Biochem Biophys Res Commun. 2022 Sep 24;622:93-100. doi: 10.1016/j.bbrc.2022.06.070. Epub 2022 Jul 4.

Abstract

PARP15, or ARTD7, is an enzyme carrying out mono-ADP-ribosylation and regulating activities of a range of cellular proteins. This enzyme belongs to the family of the poly(ADP-ribose) polymerases (PARPs), which comprises of proteins with various potential disease indications. Due to their involvement in a number of cellular processes and important role in DNA repair and regulation, PARPs have been considered attractive therapeutic targets over the past few years. The pursuit of small molecule PARP inhibitors has resulted in several FDA approved drugs for multiple cancers so far. As the use of PARP inhibitors as drug scaffolds is actively explored recently, there is increasing interest in the design of selective inhibitors based on the structural features of the PARP proteins. Here, we solved high-resolution crystal structures of the human PARP15 catalytic domain in complex with three marketed drugs of PARP inhibitors, which includes compounds 3-AB, iniparib and niraparib. The structures reported here contribute to our understanding of the ligand binding modes and structural features in the PARP15 catalytic domain, which can be employed to guide the rational design of selective inhibitors of PARPs.

摘要

PARP15,也称为 ARTD7,是一种能够进行单 ADP-核糖基化的酶,调节一系列细胞蛋白的活性。这种酶属于聚(ADP-核糖)聚合酶(PARPs)家族,该家族的蛋白具有多种潜在的疾病指征。由于其参与了许多细胞过程,并在 DNA 修复和调控中起着重要作用,PARPs 在过去几年中被认为是有吸引力的治疗靶点。小分子 PARP 抑制剂的研究已经导致了目前为止多种癌症的几种 FDA 批准药物。由于最近正在积极探索将 PARP 抑制剂作为药物支架使用,因此人们对基于 PARP 蛋白结构特征的选择性抑制剂的设计越来越感兴趣。在这里,我们解析了与人 PARP15 催化结构域与三种已上市的 PARP 抑制剂药物复合物的高分辨率晶体结构,其中包括化合物 3-AB、iniparib 和 niraparib。这里报道的结构有助于我们理解 PARP15 催化结构域中的配体结合模式和结构特征,可用于指导 PARPs 选择性抑制剂的合理设计。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验